FDA Told To Act on Avandia Five Years Ago

Safety analysts at the Food and Drug Administration told the top brass five years ago that thiazolidinediones like GlaxoSmithKline's Avandia (rosiglitazone) posed a heart attack risk to diabetics. Public Citizen released the internal memo today.